Suche ›

Molecular and Cell Biology of Human Gene Therapeutics

266,43 € Lieferbar in 5-7 Tagen
Dieses Produkt ist auch verfügbar als:


advanced metastatic disease of solid tumors, dictates that each tumor mass, indeed each individual metastasis, will have a unique antigen and cytokine environment and hence unique response to immune modu lation. A differential response to immunotherapy is thus inevitable. 4. Many of the human trials described are not randomized and report survival or response against historical controls. Most tumors described are immunogenic human tumors: renal cell cancer and melanoma are most common. In order to avoid the well-described inter-patient vari ation and rare incidence of spontaneous response among patient samples as well as selection bias and changes in practice over time, randomized trials are required. 5. Immunological treatment is unlike conventional chemotherapy in its endpoint. Most chemotherapeutic regimes require a complete response or a good partial response for cure or good palliation. There are now many cases where immunotherapy has provided long-term palliation without massive tumor reduction. Immunity may be stimulated to a degree which holds tumorigenicity in check and most importantly, pro vides good palliation for the patient in a manner that differs essentially from chemotherapy.


Titel: Molecular and Cell Biology of Human Gene Therapeutics
Autoren/Herausgeber: George Dickson (Hrsg.)
Aus der Reihe: Molecular and Cell Biology of Human Diseases Series
Ausgabe: 1995

ISBN/EAN: 9780412625503

Seitenzahl: 403
Format: 23,5 x 15,5 cm
Produktform: Hardcover/Gebunden
Gewicht: 1,700 g
Sprache: Englisch - Newsletter
Möchten Sie sich für den Newsletter anmelden?

Bitte geben Sie eine gültige E-Mail-Adresse ein.
Lieber nicht